Reading Time: 4 minutesThis is the second post in our Avoiding Risks series. Clinical trials are rapidly evolving in their design and conduct, including an explosion in the number of data sources and data points collected. Phase III trials now collect 3.6 million data points on average—a threefold increase in volume from just 10 years ago. This complex […]
Article




